Pascal Touchon - 27 Jun 2022 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
President and CEO, Director
Signature
/s/ David Tucker, Attorney-in-Fact for Pascal Touchon
Issuer symbol
ATRA
Transactions as of
27 Jun 2022
Net transactions value
-$102,384
Form type
4
Filing time
29 Jun 2022, 16:48:16 UTC
Previous filing
19 May 2022
Next filing
18 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $102,384 -14,220 -2.9% $7.20 472,093 27 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.